# Takashi Futami

> Takashi Futami is a seed investor at Astellas Venture Management backing Medical and Biopharma. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Astellas Venture Management](https://shizune.co/investors/profile/astellas-venture-management)
- Total investments: 1
- Last investment: Oct 2022
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/takashi-futami-85666294

Takashi Futami is a seed investor at Astellas Venture Management focused on Medical and Biopharma. Mr. Futami joined Astellas Venture Management in Oct 2013. Prior to joining AVM, he worked as a Senior Researcher at Astellas Pharma Inc. He served as a team leader at Oncology Labs of Astellas Pharma, and led a drug discovery research and preclinical development of kinase inhibitor programs in oncology therapeutics area. He also hasexperiences of collaboration with several institution like The University of Tokyo Hospital, Metabolex Inc. etc.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 100% |
| Biopharma | 1 | 100% |
| Therapeutics | 1 | 100% |
| Biotechnology | 1 | 100% |
| Bioinformatics | 1 | 100% |

10 industries tracked in total.

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Metagen Therapeutics | Metagen Therapeutics (MGTx) is a clinical-stage company operating Japan’s first GMP-compliant manufacturing platform for fecal microbiota transplantation (FMT) therapies. The company combines proprietary paired metagenomic datasets with AI/ML-driven donor-recipient matching to advance precision microbiome medicine across ulcerative colitis,immuno-oncology, and neurodegenerative disease. Headquartered in Tsuruoka, Japan, MGTx leverages a cross-border regulatory strategy spanning PMDA and FDA pathways, positioning it as a platform bridging Japanese clinical innovation with global market access. | $344.7K | Seed | Oct 06, 2022 |  |

1 of 1 investments shown.

## Co-investors
- [JAFCO](https://shizune.co/investors/profile/jafco-co-ltd) — VC Fund, 2 deals together
- [Keio Innovation Initiative](https://shizune.co/investors/profile/keio-innovations-initiative) — VC Fund, 1 deal together

## About Astellas Venture Management

VC Fund · Menlo Park, United States

Astellas Venture Management is a California-based financial organization that targets investments in the biotechnology sector.

5 contacts available at Astellas Venture Management.

| Name | Title | Profile |
| --- | --- | --- |
| Ken Shimokawa | Senior Investment Director | https://shizune.co/investors/profile/ken-shimokawa |
| Takashi Futami | Associate Investment Director | https://shizune.co/investors/profile/takashi-futami |
| Takatoshi Soga | Associate Investment Director | https://shizune.co/investors/profile/takatoshi-soga |
| Taro Masunaga | Investment Director | https://shizune.co/investors/profile/taro-masunaga |
| Kenji Yasukawa | President and CEO | https://shizune.co/investors/profile/kenji-yasukawa |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Takashi Futami invest in?

Takashi Futami invests primarily in Medical, Biopharma and Therapeutics startups, most often at Seed stage. Most of the 1 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Takashi Futami last invest?

The most recent investment recorded for Takashi Futami closed in Oct 2022. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co